Dissection of human humoral immune response against hepatitis C virus E2 glycoprotein by repertoire cloning and generation of recombinant Fab fragments

Hepatology

Volumn 28, Issue 3, 1998, Pages 810-814

  Burioni, Roberto ^a,e   Plaisant, Paola ^a   Manzin, Aldo ^b   Rosa, Domenico ^c   Carri, Valeria Delli ^a   Bugli, Francesca ^a   Solforosi, Laura ^b   Abrignani, Sergio ^c   Varaldo, Pietro E ^b   Fadda, Giovanni ^a   Clementi, Massimo ^d  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c CHIRON VACCINES   (Italy)

^d UNIVERSITY OF TRIESTE   (Italy)

^e CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN F(AB) FRAGMENT; VIRUS GLYCOPROTEIN;

ADULT; ANTIBODY AFFINITY; ANTIBODY PRODUCTION; ARTICLE; CASE REPORT; CROSS REACTION; EPITOPE MAPPING; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VACCINE PRODUCTION; VIRUS CELL INTERACTION; VIRUS INFECTION;

EID: 17344364478     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510280331     Document Type: Article

References (26)

1. Alter HJ, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo QL, Kuo G. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989;321:1494-1500.
2. Zibert A, Schreier E, Roggendorf M. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology 1995;208:653-661.
3. Alter HJ. In: Seef LB, Lewis JH, eds. Current Perspectives in Hepatology. New York: Plenum, 1989:83-97.
4. Seef LB and the hepatitis study group. Mortality and morbidity of transfusion-associated type C hepatitis: an NHLBI multicenter study [Abstract]. HEPATOLOGY 1994;204A.
5. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med 1992;327:1899-1905.
6. Farci P, Alter HJ, Wong DC, Miller RH, Govindarajan S, Engle R, Shapiro M, et al. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci U S A 1994;91:7792-7796.
7. Ahmed M, Shikata T, Esumi M. Murine humoral immune response against recombinant structural proteins of hepatitis C virus distinct from those of patients. Microbiol Immunol 1996;40:169-176.
8. Barbas CF, Kang AK, Lerner RA, Benkovic SJ. Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc Natl Acad Sci U S A 1991;88:7978-7982.
9. Barbas CF, Crowe JE, Cababa D, Jones TM, Zebedee SL, Murphy BR, et al. Human monoclonal Fab fragments derived from a combinatorial library-bind to respiratory syncytial virus F glycoprotein and neutralize infectivity. Proc Natl Acad Sci U S A 1992;89:10164-10168.
10. Burioni R, Williamson RA, Sanna PP, Bloom FE, Burton DR. Recombinant human Fab to glycoprotein D neutralizes infectivity and prevents cell-to-cell transmission of herpes simplex virus 1 and 2. Proc Natl Acad Sci U S A 1994;91:355-359.
11. Burton DR, Barbas CF, Persson MAA, Koenig S, Chanock RM, Lerner RA. A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proc Natl Acad Sci U S A 1991;88:10134-10137.
12. Burton DR, Pyati J, Koduri R, Sharp SJ, Thornton GB, Parren PW, Sawyer LS, et al. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 1994;266:1024-1027.
13. Williamson RA, Burioni R, PP Sanna, LJ Partridge, CF Barbas, DR Burton. Human monoclonal antibodies against a plethora of viral pathogens from single combinatorial libraries. Proc Natl Acad Sci U S A 1993;90:4141-4145.
14. Zebedee SL, Barbas CF, Hom YL, Caothien RH, Graff R, Burton DR, Lerner RA, et al. Human combinatorial antibody libraries to hepatitis B surface antigen. Proc Natl Acad Sci U S A 1992;89:3175-3179.
15. Plaisant P, Burioni R, Manzin A, Solforosi L, Candela M, Gabrielli A, Fadda G, et al. Human monoclonal recombinant Fabs specific for HCV antigens obtained by repertoire cloning in phage display combinatorial vectors. Res Virol 1997;148:165-169.
16. Burioni R, Plaisant P, DelliCarri V, Vannini A, Spanu T, Clementi M, Fadda G, et al. An improved phage display vector for antibody repertoire cloning by construction of combinatorial libraries. Res Virol 1997;148: 161-164.
17. Lesniewski R, Okasinski G, Carrick R, VanSant C, Desai S, Johnson R, Scheffel J, et al. Antibody to hepatitis C virus second envelope (HCV-E2) glycoprotein: a new marker of HCV infection closely associated with viremia. J Med Virol 1995;45:415-422.
18. Okamoto H, Sugiyama S, Okada K, Kurai Y, Akahane Y, Sugai T, Tanaka T, et al. Typing hepatitis C virus by polymerase chain reaction with type specific primers: application to clinical surveys and tracing infection sources. J Gen Virol 1992;73:673-679.
19. Barbas CF, Bjorling E, Chiodi F, Dunlop N, Cababa D, Jones TM, Zebedee SL, et al. Recombinant human Fabs neutralize human type I immunodeficiency virus in vitro. Proc Natl Acad Sci U S A 1992;89:9339-9343.
20. Geysen HM, Meloen RH, Barteling SJ. Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. Proc Natl Acad Sci U S A 1984;81:3998-4002.
21. Zhang ZX, Sonnerborg A, Sallberg M. Antigenic structure of the hepatitis C virus envelope 2 protein. Clin Exp Immunol 1994;98:382-387.
22. Rosa D, Campagnoli S, Moretto C, Guenzi E, Cousens L, Chin M, Dong C, et al. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc Natl Acad Sci U S A 1996;93:1759-1763.
23. Rath S, Stanley CM, Steward MW. An inhibition enzyme immunoassay for estimating relative antibody affinity and affinity heterogeneity. J Immunol Methods 1988;106:245-249.
24. Lai ME, Mazzoleni AP, Argiolu F, De Virgilis S, Balestrieri A, Purcell RH, Cao A, et al. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet 1994;343:388-390.
25. Parren PW, Fisicaro P, Labrijn AF, Binley JM, Yang WP, Ditzel HJ, Barbas CF, et al. In vitro antigen challenge of human antibody libraries for vaccine evaluation: the human immunodeficiency virus type 1 envelope. J Virol 1996;70:9046-9050.
26. Shimizu YK, Hijikata M, Iwamoto A, Alter HJ, Purcell RH, Yoshikura H. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol 1994;68:1494-1500.